Detailed information of effector
Summary
Effector ID | EFF01834 |
Effector type | Tme |
Cognate immunity protein | IMU00353 |
Related T6SS (Type) | T6SS01247 (Type i1) |
Strain | Vibrio parahaemolyticus strain T9109 |
Replicon | chromosome |
Sequence | Protein sequence (401 a.a.); Nucleotide sequence (1203 bp) |
Description | Tme2 was secreted in a T6SS1-dependent manner from T9109 and the tme/i2 cassette enabled T6SS1-dependent parental killing and Tme effectors target the periplasm of Gram-negative bacteria, causing membrane disruption and loss of membrane potential |
Reference |
Bioinformatics investigation has been performed
External database links
Locus tag (Gene) | PO79_RS05910 (Tme2) |
Coordinates (Strand) | 165330..166532 (+) |
NCBI ID | 835943566 |
RefSeq | NZ_JTGR01000043 |
Uniprot ID | UPI000542CA69 |
KEGG ID | - |
PDB ID | - |
Pfam domain hit(s)
Domain | Pfam ID | E-value | Aligned region |
---|
Transmembrane helices
- Transmembrane helices are predicted using TMHMM 2.0 software.
Prediction | Region | Sequence |
---|---|---|
Outside | 1-299 | MSNPESIFPKGSIAYENEQKQNPSIKSEAEAETFFPKTSIAYQNEVKANRVTPGVGKGFLPPIKKQTAFTSTQTANISPENMYWPPYDFTSGTYINTKQLPDDSLRNNLKDNQEHVMFLTLEEAFKVLQSWGWKDTQATWKSMTTSTGAQIMINYGVNGKDIVTTSMIIAQFNVHGIKATKLGLKATFGMKMSTYYNKTGTEMIKLSGYSGLRKILTGTTYRLDNPKVVQLGIGKYGLANSIKSGTVITIFVAAGFRILDYAFNDEVFLTDLVGSLATDVVKIGISSAVSAALGAASLA |
Transmembrane helix | 300-322 | FVSFVAVNLAVVVAAGLVTSIIL |
Inside | 323-400 | NELDEHYGITPKVIELLEKAQQEAVEKAEQLKENTYDSVLDLAGMLLEGVLETGKEVIESEVKRFIKKSLNELTPKIL |
Signal peptides
- Sec/SPI: "standard" secretory signal peptides transported by the Sec translocon and cleaved by Signal Peptidase I (Lep).
- Sec/SPII: lipoprotein signal peptides transported by the Sec translocon and cleaved by Signal Peptidase II (Lsp).
- Tat/SPI: Tat signal peptides transported by the Tat translocon and cleaved by Signal Peptidase I (Lep).
Prediction | Probability | Cleavage site | Signal peptide sequence |
---|---|---|---|
Other | 0.9669 | - | - |
Protein sequence: 401 a.a. .
>EFF01834 NZ_JTGR01000043:165330-166532 Type VI Membrane-disrupting Effector (Tme) [Vibrio parahaemolyticus]
MSNPESIFPKGSIAYENEQKQNPSIKSEAEAETFFPKTSIAYQNEVKANRVTPGVGKGFLPPIKKQTAFTSTQTANISPE
NMYWPPYDFTSGTYINTKQLPDDSLRNNLKDNQEHVMFLTLEEAFKVLQSWGWKDTQATWKSMTTSTGAQIMINYGVNGK
DIVTTSMIIAQFNVHGIKATKLGLKATFGMKMSTYYNKTGTEMIKLSGYSGLRKILTGTTYRLDNPKVVQLGIGKYGLAN
SIKSGTVITIFVAAGFRILDYAFNDEVFLTDLVGSLATDVVKIGISSAVSAALGAASLAFVSFVAVNLAVVVAAGLVTSI
ILNELDEHYGITPKVIELLEKAQQEAVEKAEQLKENTYDSVLDLAGMLLEGVLETGKEVIESEVKRFIKKSLNELTPKIL
*
MSNPESIFPKGSIAYENEQKQNPSIKSEAEAETFFPKTSIAYQNEVKANRVTPGVGKGFLPPIKKQTAFTSTQTANISPE
NMYWPPYDFTSGTYINTKQLPDDSLRNNLKDNQEHVMFLTLEEAFKVLQSWGWKDTQATWKSMTTSTGAQIMINYGVNGK
DIVTTSMIIAQFNVHGIKATKLGLKATFGMKMSTYYNKTGTEMIKLSGYSGLRKILTGTTYRLDNPKVVQLGIGKYGLAN
SIKSGTVITIFVAAGFRILDYAFNDEVFLTDLVGSLATDVVKIGISSAVSAALGAASLAFVSFVAVNLAVVVAAGLVTSI
ILNELDEHYGITPKVIELLEKAQQEAVEKAEQLKENTYDSVLDLAGMLLEGVLETGKEVIESEVKRFIKKSLNELTPKIL
*
Nucleotide sequence: 1203 bp .
>EFF01834 NZ_JTGR01000043:165330-166532 Type VI Membrane-disrupting Effector (Tme) [Vibrio parahaemolyticus]
ATGAGTAACCCAGAAAGCATATTTCCTAAAGGCTCGATCGCTTATGAAAACGAGCAAAAACAAAATCCTTCCATTAAATC
CGAAGCTGAAGCCGAAACCTTTTTTCCTAAGACCTCTATTGCTTATCAAAACGAAGTTAAAGCTAATAGAGTCACACCCG
GTGTTGGTAAAGGATTTCTTCCCCCAATTAAAAAGCAAACTGCTTTTACGTCGACCCAAACCGCGAATATCAGCCCTGAA
AATATGTATTGGCCGCCATATGACTTTACTTCCGGTACATACATAAACACAAAGCAATTACCTGATGATAGTTTGCGCAA
CAACCTCAAGGATAACCAAGAACATGTGATGTTTTTGACTCTTGAAGAAGCGTTTAAGGTGCTTCAGAGCTGGGGGTGGA
AGGATACTCAAGCGACTTGGAAATCAATGACAACCTCTACTGGTGCACAGATAATGATCAATTATGGTGTGAATGGTAAA
GATATTGTAACGACTTCAATGATCATTGCTCAATTTAATGTCCATGGTATCAAGGCAACCAAACTTGGATTAAAAGCCAC
TTTTGGTATGAAAATGTCGACCTACTACAACAAAACTGGCACCGAAATGATTAAATTAAGTGGCTATTCTGGCTTAAGAA
AGATACTAACAGGTACAACCTACAGGCTTGATAATCCTAAAGTAGTTCAATTGGGTATAGGCAAGTATGGGTTAGCTAAT
TCAATCAAATCAGGAACCGTTATAACAATATTTGTCGCTGCTGGGTTTAGGATCTTAGATTACGCATTCAATGACGAAGT
TTTTTTAACCGATTTAGTAGGTTCATTGGCCACAGATGTTGTAAAAATTGGTATATCTTCGGCTGTTTCCGCAGCTTTAG
GTGCAGCTTCCCTAGCCTTCGTGTCTTTTGTTGCTGTTAATCTCGCCGTTGTCGTTGCTGCTGGTCTAGTCACTTCTATT
ATACTAAACGAGCTGGATGAGCATTACGGTATCACTCCAAAAGTTATCGAACTATTAGAAAAAGCACAGCAGGAAGCTGT
TGAAAAAGCGGAACAACTAAAAGAAAATACTTATGATAGTGTTCTCGATTTAGCTGGTATGTTACTAGAAGGCGTTTTGG
AAACAGGAAAAGAAGTGATTGAGAGCGAAGTAAAACGATTCATCAAAAAATCGTTAAATGAATTGACACCAAAAATATTA
TGA
ATGAGTAACCCAGAAAGCATATTTCCTAAAGGCTCGATCGCTTATGAAAACGAGCAAAAACAAAATCCTTCCATTAAATC
CGAAGCTGAAGCCGAAACCTTTTTTCCTAAGACCTCTATTGCTTATCAAAACGAAGTTAAAGCTAATAGAGTCACACCCG
GTGTTGGTAAAGGATTTCTTCCCCCAATTAAAAAGCAAACTGCTTTTACGTCGACCCAAACCGCGAATATCAGCCCTGAA
AATATGTATTGGCCGCCATATGACTTTACTTCCGGTACATACATAAACACAAAGCAATTACCTGATGATAGTTTGCGCAA
CAACCTCAAGGATAACCAAGAACATGTGATGTTTTTGACTCTTGAAGAAGCGTTTAAGGTGCTTCAGAGCTGGGGGTGGA
AGGATACTCAAGCGACTTGGAAATCAATGACAACCTCTACTGGTGCACAGATAATGATCAATTATGGTGTGAATGGTAAA
GATATTGTAACGACTTCAATGATCATTGCTCAATTTAATGTCCATGGTATCAAGGCAACCAAACTTGGATTAAAAGCCAC
TTTTGGTATGAAAATGTCGACCTACTACAACAAAACTGGCACCGAAATGATTAAATTAAGTGGCTATTCTGGCTTAAGAA
AGATACTAACAGGTACAACCTACAGGCTTGATAATCCTAAAGTAGTTCAATTGGGTATAGGCAAGTATGGGTTAGCTAAT
TCAATCAAATCAGGAACCGTTATAACAATATTTGTCGCTGCTGGGTTTAGGATCTTAGATTACGCATTCAATGACGAAGT
TTTTTTAACCGATTTAGTAGGTTCATTGGCCACAGATGTTGTAAAAATTGGTATATCTTCGGCTGTTTCCGCAGCTTTAG
GTGCAGCTTCCCTAGCCTTCGTGTCTTTTGTTGCTGTTAATCTCGCCGTTGTCGTTGCTGCTGGTCTAGTCACTTCTATT
ATACTAAACGAGCTGGATGAGCATTACGGTATCACTCCAAAAGTTATCGAACTATTAGAAAAAGCACAGCAGGAAGCTGT
TGAAAAAGCGGAACAACTAAAAGAAAATACTTATGATAGTGTTCTCGATTTAGCTGGTATGTTACTAGAAGGCGTTTTGG
AAACAGGAAAAGAAGTGATTGAGAGCGAAGTAAAACGATTCATCAAAAAATCGTTAAATGAATTGACACCAAAAATATTA
TGA